IHM
HAE icon

Iguana Healthcare Management’s Haemonetics HAE Stock Holding History

Iguana Healthcare Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,000
Closed -$1.12M – 76
2015
Q1 		$1.12M Buy
+25,000
New +$1.05M 0.47% 52

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Iguana Healthcare Management's HAE Position: Q2 2015 in Review

Iguana Healthcare Management sold out of Haemonetics (HAE) in Q2 2015, closing a stake of 25,000 shares — an estimated $1.12M sold.

Iguana Healthcare Management first reported a position in HAE in Q1 2015 and held it in 1 quarter. The position peaked at $1.12M in Q1 2015. 181 funds tracked by Wall St. Rank hold HAE as of Q2 2015.

  • Iguana Healthcare Management reported no remaining Haemonetics position as of Q2 2015 after selling out during the quarter.
  • Iguana Healthcare Management sold 25,000 Haemonetics shares in Q2 2015, an estimated $1.12M.
  • Iguana Healthcare Management first reported a position in Haemonetics in Q1 2015 and held it in 1 quarter.
  • Iguana Healthcare Management's Haemonetics position peaked at $1.12M in Q1 2015.
  • 181 funds tracked by Wall St. Rank held Haemonetics as of Q2 2015.

Based on Iguana Healthcare Management's 13F filing for Q2 2015, filed 14 Aug 2015.